DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?

SIMPLE SUMMARY: Platinum-based agents are one of the most widely used chemotherapy drugs for various types of cancer. However, one of the main challenges in the application of platinum drugs is resistance, which is currently being widely investigated. Epigenetic DNA methylation-based biomarkers are...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavares, Nuno Tiago, Gumauskaitė, Saulė, Lobo, João, Jerónimo, Carmen, Henrique, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221086/
https://www.ncbi.nlm.nih.gov/pubmed/35740584
http://dx.doi.org/10.3390/cancers14122918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221086/
https://www.ncbi.nlm.nih.gov/pubmed/35740584
http://dx.doi.org/10.3390/cancers14122918

Ejemplares similares